Jürgen Braun Selected Research

Ankylosing Spondylitis

12/2021	Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1.
1/2021	Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT.
1/2021	Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases.
1/2021	Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence.
1/2020	Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis.
3/2019	Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study.
1/2019	[Multi-Faceted Symptoms with Joint Pain, Exanthema and Eye Involvement].
1/2019	Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.
1/2019	Sensitivity and Specificity of Autoantibodies Against CD74 in Nonradiographic Axial Spondyloarthritis.
6/2018	Dual-phase hybrid 18 F-Fluoride Positron emission tomography/MRI in ankylosing spondylitis: Investigating the link between MRI bone changes, regional hyperaemia and increased osteoblastic activity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jürgen Braun Research Topics

Disease

85	Ankylosing Spondylitis 12/2021 - 01/2002
23	Inflammation (Inflammations) 01/2021 - 10/2002
22	Axial Spondyloarthritis 01/2022 - 10/2010
20	Rheumatoid Arthritis 01/2022 - 02/2003
15	Necrosis 01/2021 - 02/2003
13	Psoriatic Arthritis 11/2021 - 01/2002
9	Pain (Aches) 01/2022 - 01/2002
9	Non-Radiographic Axial Spondyloarthritis 01/2021 - 08/2011
8	Rheumatic Diseases (Rheumatism) 03/2017 - 01/2007
7	Arthritis (Polyarthritis) 11/2022 - 01/2009
7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 02/2006
7	Back Pain (Backache) 01/2019 - 02/2006
6	Sacroiliitis 01/2021 - 07/2008
5	Infections 02/2021 - 07/2006
4	Crohn Disease (Crohn's Disease) 01/2021 - 02/2003
4	Disease Progression 09/2015 - 07/2005
3	Uveitis 01/2021 - 03/2009
2	Osteoarthritis 11/2022 - 08/2010
2	Fibrosis (Cirrhosis) 10/2021 - 05/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2009
2	Synovitis 01/2020 - 08/2010
2	Neoplasms (Cancer) 01/2020 - 11/2019
2	Fatigue 10/2017 - 08/2009
2	Portal Hypertension 01/2017 - 01/2015
2	Edema (Dropsy) 01/2016 - 08/2010
2	Neutropenia 12/2015 - 06/2015
2	Tuberculosis (Tuberculoses) 03/2015 - 10/2013
2	Spondylarthritis (Spinal Arthritis) 05/2012 - 07/2008
2	Spondylarthropathies 12/2011 - 01/2002
2	Spinal Diseases (Disease, Spinal) 08/2010 - 07/2005
1	Bone Resorption 11/2022
1	Obesity 01/2022
1	COVID-19 01/2022
1	Hepatitis 10/2021
1	Sclerosing Cholangitis 10/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021
1	Hidradenitis Suppurativa 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Ulcerative Colitis 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2020
1	Liposarcoma 01/2020
1	Hypercapnia 12/2019
1	Ankylosis 06/2018
1	Sclerosis 06/2018

Drug/Important Bio-Agent (IBA)

22	Infliximab (Remicade)FDA Link 03/2019 - 01/2002
18	C-Reactive ProteinIBA 01/2021 - 02/2005
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 01/2002
16	golimumab FDA Link 03/2019 - 11/2008
13	secukinumabIBA 12/2021 - 11/2013
13	Monoclonal AntibodiesIBA 01/2021 - 01/2002
12	Biological ProductsIBA 03/2021 - 10/2002
11	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2021 - 03/2003
10	Etanercept (Enbrel)FDA Link 11/2021 - 01/2004
10	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 07/2005
8	Antirheumatic Agents (DMARD)IBA 03/2021 - 02/2005
8	Adalimumab (Humira)FDA Link 01/2021 - 01/2004
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017 - 11/2006
8	Pharmaceutical PreparationsIBA 08/2014 - 11/2006
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2010
7	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 03/2010
6	Interleukin-17 (Interleukin 17)IBA 01/2018 - 11/2013
5	GlucocorticoidsIBA 06/2017 - 09/2014
4	Certolizumab Pegol FDA Link 01/2022 - 01/2017
4	Biosimilar PharmaceuticalsIBA 11/2021 - 10/2013
4	CytokinesIBA 01/2021 - 03/2003
4	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2019 - 02/2006
4	CT-P13IBA 02/2017 - 10/2013
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2012 - 01/2009
3	AntibodiesIBA 01/2020 - 10/2013
3	Interleukin-6 (Interleukin 6)IBA 12/2016 - 08/2009
2	Dopamine Receptors (Dopamine Receptor)IBA 11/2022 - 01/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 02/2014
2	Immunoglobulin G (IgG)IBA 01/2019 - 07/2006
2	Prostaglandins AIBA 10/2017 - 08/2010
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 09/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 12/2014
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2015 - 06/2011
1	Tolonium Chloride FDA Link 11/2022
1	COVID-19 VaccinesIBA 01/2022
1	ixekizumabIBA 01/2022
1	LipidsIBA 01/2022
1	RA 25IBA 11/2021
1	Antiviral Agents (Antivirals)IBA 02/2021
1	daclatasvirIBA 02/2021
1	SofosbuvirIBA 02/2021
1	Fluconazole (Zonal)FDA LinkGeneric 01/2021
1	Carbon DioxideIBA 12/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	AutoantibodiesIBA 01/2019
1	FluoridesIBA 06/2018

Therapy/Procedure

33	Therapeutics 01/2022 - 01/2002
4	Aftercare (After-Treatment) 02/2021 - 05/2006
3	Transjugular Intrahepatic Portasystemic Shunt 01/2017 - 02/2014
3	Biological Therapy 01/2017 - 10/2010
3	Subcutaneous Injections 12/2012 - 11/2008
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2015 - 02/2014
1	Drug Tapering 03/2021